Literature DB >> 19906520

A profile of volatile organic compounds in breath discriminates COPD patients from controls.

J J B N Van Berkel1, J W Dallinga, G M Möller, R W L Godschalk, E J Moonen, E F M Wouters, F J Van Schooten.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is an inflammatory condition characterized by oxidative stress and the formation of volatile organic compounds (VOCs) secreted via the lungs. We recently developed a methodological approach able to identify profiles of VOCs in breath unique for patient groups. Here we applied this recently developed methodology regarding diagnosis of COPD patients.
METHODS: Fifty COPD patients and 29 controls provided their breath and VOCs were analyzed by gas chromatography-mass spectrometry to identify relevant VOCs. An additional 16 COPD patients and 16 controls were sampled in order to validate the model, and 15 steroid naïve COPD patients were sampled to determine whether steroid use affects performance.
FINDINGS: 1179 different VOCs were detected, of which 13 were sufficient to correctly classify all 79 subjects. Six of these 13 VOCs classified 92% of the subjects correctly (sensitivity: 98%, specificity: 88%) and correctly classified 29 of 32 subjects (sensitivity: 100%, specificity: 81%) from the independent validation population. Fourteen out of 15 steroid naïve COPD patients were correctly classified thus excluding treatment influences.
INTERPRETATION: This is the first study distinguishing COPD subjects from controls solely based on the presence of VOCs in breath. Analysis of VOCs might be highly relevant for diagnosis of COPD. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19906520     DOI: 10.1016/j.rmed.2009.10.018

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  44 in total

Review 1.  Functional analysis of colonic bacterial metabolism: relevant to health?

Authors:  Henrike M Hamer; Vicky De Preter; Karen Windey; Kristin Verbeke
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-10-20       Impact factor: 4.052

Review 2.  Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases.

Authors:  Shivani Ghaisas; Joshua Maher; Anumantha Kanthasamy
Journal:  Pharmacol Ther       Date:  2015-11-26       Impact factor: 12.310

Review 3.  Electronic Nose Technology in Respiratory Diseases.

Authors:  Silvano Dragonieri; Giorgio Pennazza; Pierluigi Carratu; Onofrio Resta
Journal:  Lung       Date:  2017-02-25       Impact factor: 2.584

Review 4.  Breathomics for the clinician: the use of volatile organic compounds in respiratory diseases.

Authors:  Wadah Ibrahim; Liesl Carr; Rebecca Cordell; Michael J Wilde; Dahlia Salman; Paul S Monks; Paul Thomas; Chris E Brightling; Salman Siddiqui; Neil J Greening
Journal:  Thorax       Date:  2021-01-07       Impact factor: 9.139

5.  Volatile Organic Compounds in Exhaled Breath of Idiopathic Pulmonary Fibrosis for Discrimination from Healthy Subjects.

Authors:  Yu-Ichi Yamada; Gen Yamada; Mitsuo Otsuka; Hirotaka Nishikiori; Kimiyuki Ikeda; Yasuaki Umeda; Hirofumi Ohnishi; Koji Kuronuma; Hirofumi Chiba; Jörg Ingo Baumbach; Hiroki Takahashi
Journal:  Lung       Date:  2017-03-01       Impact factor: 2.584

6.  Bronchoscopically obtained volatile biomarkers in lung cancer.

Authors:  Kaid Darwiche; Joerg Ingo Baumbach; Urte Sommerwerck; Helmut Teschler; Lutz Freitag
Journal:  Lung       Date:  2011-10-04       Impact factor: 2.584

Review 7.  Clinical implications of shared genetics and pathogenesis in autoimmune diseases.

Authors:  Alexandra Zhernakova; Sebo Withoff; Cisca Wijmenga
Journal:  Nat Rev Endocrinol       Date:  2013-08-20       Impact factor: 43.330

8.  A new method to evaluate macaque health using exhaled breath: A case study of M. tuberculosis in a BSL-3 setting.

Authors:  Theodore R Mellors; Lionel Blanchet; JoAnne L Flynn; Jaime Tomko; Melanie O'Malley; Charles A Scanga; Philana L Lin; Jane E Hill
Journal:  J Appl Physiol (1985)       Date:  2017-01-05

9.  A mobile instrumentation platform to distinguish airway disorders.

Authors:  Michael Schivo; Felicia Seichter; Alexander A Aksenov; Alberto Pasamontes; Daniel J Peirano; Boris Mizaikoff; Nicholas J Kenyon; Cristina E Davis
Journal:  J Breath Res       Date:  2013-02-27       Impact factor: 3.262

10.  Comprehensive Two-Dimensional Gas Chromatography-Mass Spectrometry Analysis of Exhaled Breath Compounds after Whole Grain Diets.

Authors:  Kaisa Raninen; Ringa Nenonen; Elina Järvelä-Reijonen; Kaisa Poutanen; Hannu Mykkänen; Olavi Raatikainen
Journal:  Molecules       Date:  2021-05-02       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.